查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质体学市场：仪器、按试剂、按服务、按软体、按应用 - 预测（~2029 年）
市场调查报告书
商品编码
1563532

全球蛋白质体学市场：仪器、按试剂、按服务、按软体、按应用 - 预测（~2029 年）

Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray (Protein Chips)), Reagents, Services (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 798 Pages | 订单完成后即时交付

价格

全球蛋白质体学市场规模预计将从 2024 年的 336 亿美元增至 2029 年的 605 亿美元，并预计在 2024-2029 年预测期间复合年增长率为 12.4%。

调查范围
调查年份 2021-2029
基准年 2023年
预测期 2024-2029
单元 10亿美元
部分 仪器、试剂、服务、软体、应用程式、最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

“光谱学领域占据着压倒性的市场份额。”

光谱提供了有关蛋白质结构、大小、形状、二级或三级结构、定量、与其他分子（如配体、溶质和其他蛋白质）相互作用的信息，并且越来越多地用于蛋白质分析，占48.8%的最大份额。

“免疫测量试剂在试剂领域占据主导地位。”

在试剂领域，免疫检测试剂占据最大份额，达到26.5%，而光谱试剂预计在预测期内将以显着的复合年增长率成长。越来越多地使用基于定性定量分析的技术、开发高通量定性定量分析方法以及对个人化医疗日益增长的兴趣等因素可能会推动该细分市场的成长。

“在预测期内，生物製药公司领域可能会以显着的复合年增长率增长。”

由于大型製药企业更加关注新分子的发现和开发、生物标誌物的识别以及个人化医疗的研发等核心活动，生物製药公司细分市场正在成长，这在蛋白质组学市场中占据了最大的份额。 39.1%。

“预计亚太地区的成长率最高。”

2023年，北美将占据蛋白质体学市场的主要份额。由于蛋白质体学和基因组学研究领域的扩大以及研究资金筹措的增加等多种因素，亚太地区在预测期内可能会以显着的复合年增长率增长。生物製药公司投资的增加和单株抗体疗法领域研究活动的活性化预计将推动该地区的市场扩张。

本报告研究和分析了全球蛋白质体学市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

  • 蛋白质体学市场概述
  • 北美蛋白质体学市场：依应用分类（2023）
  • 光谱仪器技术市场：依类型（2024/2029）
  • 蛋白质体学市场：地理成长机会

第五章市场概况

  • 介绍
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 影响客户业务的趋势/干扰
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 价格分析
    • 蛋白质体学仪器市场销售价格趋势：按地区（2021-2023）
    • 蛋白质体学仪器平均销售价格趋势：按地区（2023 年）
  • 价值链分析
  • 供应链分析
  • 生态系分析
    • 蛋白质体学产品/服务供应商
    • 最终用户
    • 监管机构
  • 专利分析
  • 贸易分析
    • 层析法/电泳设备进口资料（HS编码：902720）
    • 层析法/电泳设备出口资料（HS编码：902720）
    • 质谱仪进口资料（HS编码：902781）
    • 质谱仪出口资料（HS编码：902781）
  • 重大会议和活动（2024-2025）
  • 监管环境
    • 监管场景
    • 监管机构、政府机构和其他组织
  • 投资金筹措场景
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 人工智慧/产生人工智慧对蛋白质体学市场的影响

第六章蛋白质体学市场：依仪器技术分类

  • 介绍
  • 光谱学
    • 定性定量分析
    • 核磁共振波谱
    • 圆二色光谱法
  • 层析法
    • 高效液相层析法
    • 离子层析法
    • 亲和性和层析法
    • 超临界流体层析法
  • 电泳
    • 凝胶电泳
    • 毛细管电泳
  • 蛋白质微阵列
    • 生物晶片
    • 微阵列仪器
  • X射线结晶结构分析
  • 表面等离子体共振
  • 蛋白质部分
  • 其他仪器技术

第七章蛋白质体学市场：依试剂分类

  • 介绍
  • 免疫检测试剂
  • 光谱试剂
  • 层析法试剂
  • 蛋白质微阵列试剂
  • X射线结晶结构分析试剂
  • 电泳试剂
  • 蛋白质分级分离试剂
  • 其他试剂

第 8 章蛋白质体学市场：依服务分类

  • 介绍
  • 核心蛋白质体学服务
    • 蛋白质鑑定服务
    • 定量蛋白质体学服务
    • 蛋白质表征服务
    • 蛋白质精製服务
    • 蛋白质分离服务
    • 蛋白质序列分析服务
    • 自订化验服务
  • 生物资讯服务

第 9 章蛋白质体市场：透过软体

  • 介绍
    • 生物资讯学工具
    • 生物资讯资料库

第10章蛋白质体学市场：依应用分类

  • 介绍
  • 临床诊断
    • 癌症
    • 感染疾病
    • 糖尿病
    • 神经系统疾病
    • 自体免疫疾病
    • 心血管疾病
    • 其他临床诊断应用
  • 药物发现/开发
    • 寻找目标
    • 线索识别
    • 先导药物最适化
    • 临床前研究
  • 其他用途

第十一章蛋白质体学市场：依最终用户分类

  • 介绍
  • 生物製药公司
  • 学术研究所
  • 医院
  • 临床实验室
  • 其他最终用户

第十二章蛋白质体市场：按地区

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 瑞士
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东
    • 中东宏观经济展望
    • 海湾合作委员会国家
    • 其他中东地区
  • 非洲

第十三章竞争格局

  • 介绍
  • 主要企业策略/主要企业
  • 收益分析（2021-2023）
  • 市场占有率分析（2023）
  • 企业评价矩阵：主要企业（2023年）
  • 企业评估矩阵：Start-Ups/中小企业（2023）
  • 公司评价及财务指标
  • 品牌/产品比较
  • 竞争场景

第十四章 公司简介

  • 主要企业
    • THERMO FISHER SCIENTIFIC INC.
    • AGILENT TECHNOLOGIES, INC.
    • MERCK KGAA
    • DANAHER CORPORATION
    • SHIMADZU CORPORATION
    • WATERS CORPORATION
    • BIO-RAD LABORATORIES, INC.
    • BRUKER
    • REVVITY
    • ILLUMINA, INC.
    • PROMEGA CORPORATION
    • EUROFINS SCIENTIFIC
    • QIAGEN
    • CHARLES RIVER LABORATORIES
    • PROTAGENE
  • 其他公司
    • CREATIVE PROTEOMICS, US
    • HORIBA JAPAN LTD.
    • SENGENICS CORPORATION LLC
    • LABVANTAGE-BIOMAX GMBH
    • FIOS GENOMICS
    • AZENTA US, INC.
    • MEDGENOME
    • BIOGNOSYS AG
    • MACROGEN, INC.
    • CELL SIGNALING TECHNOLOGY, INC.

第十五章附录

Product Code: BT 2341

The global proteomics market is estimated to reach USD 60.5 billion by 2029 from USD 33.6 billion in 2024, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsInstrumentation, Reagents, Services, Software, Application and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa

"The spectroscopy segment holds dominant share in the proteomics market."

Based on the technology, the proteomics market is divided into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment accounted for the largest share of 48.8% owing to factors such as technique is increased use in protein analysis, providing information about protein structure, size, shape, secondary or tertiary conformation, quantification, and interaction with other molecules, such as ligands, solutes, or other proteins.

"The immunoassay reagent dominated the reagent segments."

Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents accounted for the largest share of 26.5% of the reagent segment however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques and increasing interest in personalized medicine are likely to drive the segmental growth.

"Biopharmaceutical companies segment is likely to grow at significant CAGR during the forecast period"

Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment accounted for the largest share of 39.1% of the proteomics market owing to rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules, identification of biomarkers and personalized medicine.

"Asia Pacific region estimated to show fastest growth rate."

Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70%, and Demand Side - 30%
  • By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%

List of Companies Profiled in the Report:

  • Thermo fisher Scientific Inc (US)
  • Agilent Technologies, Inc. (US)
  • Merck KGaA (Germany)
  • Danaher Corporation (US)
  • Waters Corporation (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Bruker Corporation (US)
  • Revvity (US)
  • Shimadzu Corporation (Japan)
  • Illumina Inc (US)
  • Promega Corporation (US)
  • Eurofins Scientific (Luxembourg)
  • Qiagen (Netherlands)
  • Charles River Laboratories (US)
  • Protagene (Germany)
  • Creative Proteomics (US)
  • Horiba (Japan)
  • Sengenics Corporation LLC (US)
  • Labvantage-Biomax GmbH (Germany)
  • Cell Signaling Technology, Inc. (US)
  • FIOS Genomics (UK)
  • Azenta Life Sciences (US)
  • Medgenome (India)
  • Biognosys AG (Switzerland)
  • Macrogen Inc (South Korea)

Research Coverage:

This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments such as technology, reagent, service, software, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key Drivers (Growing demand for personalized medicines for clinical practices, Increased investments in proteomics research and development, Rising Application in Drug Discovery and Development and Government and Private Funding) restraints (High costs of proteomics instruments and technologies, Lack of standardization in proteomics techniques) opportunities (Advancements in Bioinformatics, Advancements in Single-Cell Proteomics and Collaborations and Partnerships) and challenges (Lack of data management/handling in proteomics research) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the proteomics market.
  • Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the proteomics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products offerings of leading players like Thermo fisher Scientific Inc (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Revvity (US), Shimadzu Corporation (Japan), Illumina Inc (US), Promega Corporation (US), Eurofins (Luxembourg), Qiagen (Netherlands), Charles River Laboratories (US), Protagene (Germany), Creative Proteomics (US), Horiba (Japan), Sengenics Corporation LLC (US), Labvantage-Biomax GmbH (Germany), Cell Signaling Technology, Inc. (US), FIOS Genomics (UK), Azenta Life Sciences (US), Medgenome (India), Biognosys AG (Switzerland) and Macrogen Inc (South Korea).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Objectives of primary research
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
    • 2.2.2 MNM REPOSITORY ANALYSIS
    • 2.2.3 PRIMARY INTERVIEWS
    • 2.2.4 SECONDARY RESEARCH
    • 2.2.5 INSIGHTS FROM PRIMARIES
    • 2.2.6 TOP-DOWN APPROACH
    • 2.2.7 MARKET GROWTH RATE PROJECTIONS
  • 2.3 DATA TRIANGULATION
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PROTEOMICS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2023
  • 4.3 SPECTROSCOPY INSTRUMENTATION TECHNOLOGY MARKET, BY TYPE, 2024 VS. 2029
  • 4.4 PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for personalized medicines in clinical practices
      • 5.2.1.2 High investments in pharmaceutical R&D
      • 5.2.1.3 Rising applications in drug discovery and development
      • 5.2.1.4 Increased private and government funding
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High costs of proteomics instruments and technologies
      • 5.2.2.2 Lack of standardization
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancements in bioinformatics
      • 5.2.3.2 Developments in single-cell proteomics research
      • 5.2.3.3 Increasing number of collaborations and strategic partnerships
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of data management and handling
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Mass spectrometry
        • 5.4.1.1.1 Intact or top-down protein analysis
      • 5.4.1.2 Chromatography
      • 5.4.1.3 Protein microarrays
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Transcriptomics
      • 5.4.2.2 Metabolomics
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Single-cell proteomics
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE SELLING PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021-2023
    • 5.5.2 AVERAGE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS, BY REGION, 2023
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 PROTEOMICS PRODUCT AND SERVICE PROVIDERS
    • 5.8.2 END USERS
    • 5.8.3 REGULATORY BODIES
  • 5.9 PATENT ANALYSIS
    • 5.9.1 METHODOLOGY
    • 5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2013-2024
    • 5.9.3 INNOVATION AND PATENT APPLICATION
    • 5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF APPLICATIONS
    • 5.9.5 TOP 10 PATENT OWNERS
    • 5.9.6 KEY PATENTS IN PROTEOMICS MARKET
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
    • 5.10.2 EXPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
    • 5.10.3 IMPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
    • 5.10.4 EXPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
  • 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.12 REGULATORY LANDSCAPE
    • 5.12.1 REGULATORY SCENARIO
      • 5.12.1.1 North America
      • 5.12.1.2 Europe
      • 5.12.1.3 Asia Pacific
      • 5.12.1.4 Rest of the world
    • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13 INVESTMENT AND FUNDING SCENARIO
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT OF NEW ENTRANTS
    • 5.14.2 THREAT OF SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF BUYERS
    • 5.14.4 BARGAINING POWER OF SUPPLIERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
    • 5.15.2 KEY BUYING CRITERIA
  • 5.16 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET

6 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 SPECTROSCOPY
    • 6.2.1 MASS SPECTROMETRY
      • 6.2.1.1 High specificity and technological advancements to propel segment growth
    • 6.2.2 NMR SPECTROSCOPY
      • 6.2.2.1 Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth
    • 6.2.3 CD SPECTROSCOPY
      • 6.2.3.1 Non-destructive and non-invasive techniques to examine changes in secondary protein structures
  • 6.3 CHROMATOGRAPHY
    • 6.3.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
      • 6.3.1.1 High resolution, sensitivity, and reproducibility to spur segment growth
    • 6.3.2 ION CHROMATOGRAPHY
      • 6.3.2.1 High resolving power, simplicity, and controllability to separate and purify proteins
    • 6.3.3 AFFINITY CHROMATOGRAPHY
      • 6.3.3.1 High specificity for target proteins and easy identification of novel protein interactions to drive segment
    • 6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
      • 6.3.4.1 Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth
  • 6.4 ELECTROPHORESIS
    • 6.4.1 GEL ELECTROPHORESIS
      • 6.4.1.1 Increasing demand for proteomics research and personalized medicine to boost segment growth
    • 6.4.2 CAPILLARY ELECTROPHORESIS
      • 6.4.2.1 Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market
  • 6.5 PROTEIN MICROARRAYS
    • 6.5.1 BIOCHIPS
      • 6.5.1.1 Lab-on-chips
        • 6.5.1.1.1 Rising focus on microfabrication and nanotechnology development to aid segment growth
      • 6.5.1.2 Protein chips
        • 6.5.1.2.1 Competitive advantage over conventional protein analysis tools to propel segment growth
    • 6.5.2 MICROARRAY INSTRUMENTS
      • 6.5.2.1 Integrated systems
        • 6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins
      • 6.5.2.2 Microarray scanners
        • 6.5.2.2.1 Cost-effective and high-quality analysis to propel segment growth
      • 6.5.2.3 Arrayers
        • 6.5.2.3.1 Technological advancements to drive adoption of arrayers in large-scale projects
  • 6.6 X-RAY CRYSTALLOGRAPHY
    • 6.6.1 RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH
  • 6.7 SURFACE PLASMON RESONANCE
    • 6.7.1 INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH
  • 6.8 PROTEIN FRACTIONATION
    • 6.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES
  • 6.9 OTHER INSTRUMENTATION TECHNOLOGIES

7 PROTEOMICS MARKET, BY REAGENT

  • 7.1 INTRODUCTION
  • 7.2 IMMUNOASSAY REAGENTS
    • 7.2.1 NEED FOR RELIABLE, SPECIFIC, AND FAST DISEASE DETECTION AT EARLY STAGES TO FAVOR MARKET GROWTH
  • 7.3 SPECTROSCOPY REAGENTS
    • 7.3.1 INCREASED ADOPTION OF HIGH-THROUGHPUT MASS SPECTROSCOPY-BASED TECHNIQUES TO AID MARKET GROWTH
  • 7.4 CHROMATOGRAPHY REAGENTS
    • 7.4.1 BETTER ACCURACY AND LOWER DETECTION LIMITS TO FACILITATE SEGMENT GROWTH
  • 7.5 PROTEIN MICROARRAY REAGENTS
    • 7.5.1 DEVELOPMENT OF NOVEL AND ADVANCED PROTEIN ANALYSIS REAGENTS TO PROPEL MARKET GROWTH
  • 7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
    • 7.6.1 EMERGENCE OF NEW TARGETS FOR DRUG DISCOVERY AND HIGH R&D INVESTMENTS TO SUPPORT MARKET GROWTH
  • 7.7 ELECTROPHORESIS REAGENTS
    • 7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS TO AUGMENT MARKET GROWTH
  • 7.8 PROTEIN FRACTIONATION REAGENTS
    • 7.8.1 RISING NEED FOR PROTEIN FRACTIONATION TECHNIQUES TO AUGMENT MARKET GROWTH
  • 7.9 OTHER REAGENTS

8 PROTEOMICS MARKET, BY SERVICE

  • 8.1 INTRODUCTION
  • 8.2 CORE PROTEOMICS SERVICES
    • 8.2.1 PROTEIN IDENTIFICATION SERVICES
      • 8.2.1.1 Rising need for protein identification and molecular weight analysis to boost market growth
    • 8.2.2 QUANTITATIVE PROTEOMICS SERVICES
      • 8.2.2.1 Rapid and low-cost alternatives to help understand global protein expression and modifications
    • 8.2.3 PROTEIN CHARACTERIZATION SERVICES
      • 8.2.3.1 Characterization studies to help study complex protein structure, drug development, and PTMs
    • 8.2.4 PROTEIN PURIFICATION SERVICES
      • 8.2.4.1 Protein purification to maximize yield and purity of protein of interest
    • 8.2.5 PROTEIN SEPARATION SERVICES
      • 8.2.5.1 Technological advancements and use in downstream applications to augment segment growth
    • 8.2.6 PROTEIN SEQUENCING SERVICES
      • 8.2.6.1 Identification and characterization of PTMs to favor protein sequencing and research
    • 8.2.7 CUSTOM ASSAY SERVICES
      • 8.2.7.1 Custom assays to improve validation or consistency of protein analysis procedures
  • 8.3 BIOINFORMATICS SERVICES
    • 8.3.1 LESSER ANALYSIS TIME AND FAVORABLE GOVERNMENT INITIATIVES TO SPUR MARKET GROWTH

9 PROTEOMICS MARKET, BY SOFTWARE

  • 9.1 INTRODUCTION
    • 9.1.1 BIOINFORMATICS TOOLS
      • 9.1.1.1 Need for data management and advancements in bioinformatics to augment market growth
    • 9.1.2 BIOINFORMATICS DATABASES
      • 9.1.2.1 Need to store proteomics data and integrate other omics databases to drive market

10 PROTEOMICS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 CLINICAL DIAGNOSTICS
    • 10.2.1 CANCER
      • 10.2.1.1 Rising prevalence of cancer to propel market growth
    • 10.2.2 INFECTIOUS DISEASES
      • 10.2.2.1 Technological advancements and need for effective disease diagnosis to support market growth
    • 10.2.3 DIABETES
      • 10.2.3.1 Need for advanced diagnostic technologies and high diabetes prevalence to aid market growth
    • 10.2.4 NEUROLOGICAL DISORDERS
      • 10.2.4.1 Growing target patient population and increasing research grants to fuel market growth
    • 10.2.5 AUTOIMMUNE DISEASES
      • 10.2.5.1 Increasing patient population and growing focus on immunology-based research to propel market growth
    • 10.2.6 CARDIOVASCULAR DISEASES
      • 10.2.6.1 High burden of cardiovascular diseases to spur adoption of reliable diagnostic tools
    • 10.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
  • 10.3 DRUG DISCOVERY & DEVELOPMENT
    • 10.3.1 TARGET DISCOVERY
      • 10.3.1.1 Increased demand for personalized medicine to support segment growth
    • 10.3.2 LEAD IDENTIFICATION
      • 10.3.2.1 Lead identification to be essential in drug discovery and characterization
    • 10.3.3 LEAD OPTIMIZATION
      • 10.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth
    • 10.3.4 PRECLINICAL STUDIES
      • 10.3.4.1 Integration of proteomics in preclinical studies to refine drug safety and efficacy
  • 10.4 OTHER APPLICATIONS

11 PROTEOMICS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 BIOPHARMACEUTICAL COMPANIES
    • 11.2.1 LOW OPERATING COSTS AND RAPID DRUG ANALYSIS TO DRIVE MARKET
  • 11.3 ACADEMIC AND RESEARCH INSTITUTES
    • 11.3.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO BOOST MARKET GROWTH
  • 11.4 HOSPITALS
    • 11.4.1 GROWING PREVALENCE OF IMMUNODEFICIENCY DISEASES AND SERUM PROTEIN DISORDERS TO BOOST MARKET GROWTH
  • 11.5 CLINICAL LABORATORIES
    • 11.5.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO SUPPORT MARKET GROWTH
  • 11.6 OTHER END USERS

12 PROTEOMICS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 US to dominate North American proteomics market during study period
    • 12.2.3 CANADA
      • 12.2.3.1 Favorable government initiatives and high incidence of cancer to support market growth
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Well-established pharmaceutical industry and increased government funding to augment market growth
    • 12.3.3 UK
      • 12.3.3.1 Developed life science industry and increased academia-industry partnerships to augment market growth
    • 12.3.4 FRANCE
      • 12.3.4.1 High investments in life science R&D and increased demand for personalized therapeutics to aid market growth
    • 12.3.5 SWITZERLAND
      • 12.3.5.1 Well-established pharmaceutical and biotechnology industry and increased investments in life science R&D to drive market
    • 12.3.6 ITALY
      • 12.3.6.1 High private and public R&D funding and favorable government initiatives to favor market growth
    • 12.3.7 SPAIN
      • 12.3.7.1 Well-established network of research centers, universities, and hospitals to aid market growth
    • 12.3.8 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Rising government R&D investments and increasing focus on healthcare product manufacturing to fuel market growth
    • 12.4.3 JAPAN
      • 12.4.3.1 Large geriatric population and strong pharmaceutical research base to drive market
    • 12.4.4 INDIA
      • 12.4.4.1 Increasing focus on proteomics and genomic research to support market growth
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Developed medical tourism and advanced healthcare infrastructure to propel market growth
    • 12.4.6 AUSTRALIA
      • 12.4.6.1 Favorable government initiatives and high R&D investments to favor market growth
    • 12.4.7 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Increasing contract research and manufacturing activities to drive market
    • 12.5.3 MEXICO
      • 12.5.3.1 Strong pharmaceutical industry and increased government support to augment market growth
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Saudi Arabia
        • 12.6.2.1.1 Increasing government healthcare investments and developing pharmaceuticals industry to boost market growth
      • 12.6.2.2 UAE
        • 12.6.2.2.1 High R&D expenditure and developed health infrastructure to drive market
      • 12.6.2.3 Rest of GCC Countries
    • 12.6.3 REST OF MIDDLE EAST
  • 12.7 AFRICA
    • 12.7.1 FAVORABLE GOVERNMENT INITIATIVES AND ADVANCEMENTS IN PERSONALIZED MEDICINES TO PROPEL MARKET GROWTH
    • 12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET
  • 13.3 REVENUE ANALYSIS, 2021-2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Instrumentation technology footprint
      • 13.5.5.3 Reagent footprint
      • 13.5.5.4 Service footprint
      • 13.5.5.5 Software footprint
      • 13.5.5.6 Region footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 THERMO FISHER SCIENTIFIC INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Services/Solutions offered
    • 14.1.2 RECENT DEVELOPMENTS
      • 14.1.2.1 Product launches
      • 14.1.2.2 Deals
      • 14.1.2.3 MnM view
        • 14.1.2.3.1 Key strengths
        • 14.1.2.3.2 Strategic choices
        • 14.1.2.3.3 Weaknesses and competitive threats
    • 14.1.3 AGILENT TECHNOLOGIES, INC.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Services/Solutions offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches
        • 14.1.3.3.2 Deals
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 MERCK KGAA
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Services/Solutions offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Key strengths
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 DANAHER CORPORATION
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Services/Solutions offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Product launches
        • 14.1.5.3.2 Deals
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strengths
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 SHIMADZU CORPORATION
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Services/Solutions offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product launches
        • 14.1.6.3.2 Expansions
      • 14.1.6.4 MnM view
        • 14.1.6.4.1 Key strengths
        • 14.1.6.4.2 Strategic choices
        • 14.1.6.4.3 Weaknesses and competitive threats
    • 14.1.7 WATERS CORPORATION
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Services/Solutions offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product launches
        • 14.1.7.3.2 Deals
    • 14.1.8 BIO-RAD LABORATORIES, INC.
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Services/Solutions offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches
    • 14.1.9 BRUKER
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Services/Solutions offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Product launches
        • 14.1.9.3.2 Deals
    • 14.1.10 REVVITY
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Services/Solutions offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Deals
    • 14.1.11 ILLUMINA, INC.
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products/Services/Solutions offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Deals
    • 14.1.12 PROMEGA CORPORATION
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products/Services/Solutions offered
    • 14.1.13 EUROFINS SCIENTIFIC
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products/Services/Solutions offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Deals
    • 14.1.14 QIAGEN
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products/Services/Solutions offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Product launches
        • 14.1.14.3.2 Deals
    • 14.1.15 CHARLES RIVER LABORATORIES
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products/Services/Solutions offered
      • 14.1.15.3 Recent developments
        • 14.1.15.3.1 Product launches
        • 14.1.15.3.2 Deals
    • 14.1.16 PROTAGENE
      • 14.1.16.1 Business overview
      • 14.1.16.2 Products/Services/Solutions offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 CREATIVE PROTEOMICS, US
    • 14.2.2 HORIBA JAPAN LTD.
    • 14.2.3 SENGENICS CORPORATION LLC
    • 14.2.4 LABVANTAGE-BIOMAX GMBH
    • 14.2.5 FIOS GENOMICS
    • 14.2.6 AZENTA US, INC.
    • 14.2.7 MEDGENOME
    • 14.2.8 BIOGNOSYS AG
    • 14.2.9 MACROGEN, INC.
    • 14.2.10 CELL SIGNALING TECHNOLOGY, INC.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 PROTEOMICS MARKET: RISK ANALYSIS
  • TABLE 4 INDICATIVE PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021-2023 (USD)
  • TABLE 5 PROTEOMICS PRODUCT AND SERVICE PROVIDERS: ROLE IN ECOSYSTEM
  • TABLE 6 END USERS: ROLE IN ECOSYSTEM
  • TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
  • TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2013-AUGUST 2024
  • TABLE 9 PROTEOMICS MARKET: TOP 10 PATENT OWNERS, 2013-2023
  • TABLE 10 KEY PATENTS IN PROTEOMICS MARKET, 2021-2024
  • TABLE 11 IMPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019-2023 (TON)
  • TABLE 12 EXPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019-2023 (TON)
  • TABLE 13 IMPORT VOLUME FOR MASS SPECTROMETERS (HS CODE: 902781), 2022-2023 (USD)
  • TABLE 14 EXPORT VOLUME FOR MASS SPECTROMETERS (HS CODE-902781), 2022-2023 (USD)
  • TABLE 15 PROTEOMICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024-DECEMBER 2025
  • TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 PROTEOMICS MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 22 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 23 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 24 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 MASS SPECTROMETRY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 NMR SPECTROSCOPY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 CD SPECTROSCOPY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 53 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 ION CHROMATOGRAPHY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 GEL ELECTROPHORESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 BIOCHIPS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 MIDDLE EAST: BIOCHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 GCC COUNTRIES: BIOCHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 LAB-ON-CHIPS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 MIDDLE EAST: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 GCC COUNTRIES: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 PROTEIN CHIPS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 MIDDLE EAST: PROTEIN CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 GCC COUNTRIES: PROTEIN CHIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 142 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 INTEGRATED SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 MICROARRAY SCANNERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 ARRAYERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 178 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 185 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 188 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 189 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 191 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 192 EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 193 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 195 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 PROTEOMICS MARKETS, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 198 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 200 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 205 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 207 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 210 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 213 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 214 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 220 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 221 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 227 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 228 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 232 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 233 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 234 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 235 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 240 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 242 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 245 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 247 PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 248 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 249 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 251 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 254 PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 255 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 CORE PROTEOMICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 258 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 260 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 263 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 265 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 267 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 269 GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 270 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 271 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 272 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 274 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 277 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 278 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 279 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2022-2029 (USD MILLION)
  • TABLE 282 MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 284 PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 285 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 286 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 287 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 289 MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 290 GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 291 PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 292 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 293 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 295 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 296 MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 297 GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 298 PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 299 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 300 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 301 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 302 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 303 MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 304 GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 305 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 306 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 307 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 309 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 310 MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 311 GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 312 BIOINFORMATICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 313 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 314 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 316 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 317 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 318 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 319 PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 320 PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 321 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 322 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 325 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 327 PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 328 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 329 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 331 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 333 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 334 PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 335 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 337 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 338 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 340 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 341 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 342 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 343 CANCER MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 344 NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 345 EUROPE: CANCER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 348 MIDDLE EAST: CANCER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: CANCER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 350 INFECTIOUS DISEASES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 351 NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 352 EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 354 LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 357 DIABETES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 358 NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 359 EUROPE: DIABETES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 360 ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 361 LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 362 MIDDLE EAST: DIABETES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: DIABETES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 364 NEUROLOGICAL DISORDERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 365 NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 366 EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 367 ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 368 LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 369 MIDDLE EAST: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 371 AUTOIMMUNE DISEASES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 372 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 373 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 374 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 375 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 376 MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 377 GCC COUNTRIES: PROTEOMICS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 378 CARDIOVASCULAR DISEASES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 379 NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 380 EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 382 LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 383 MIDDLE EAST: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 384 GCC COUNTRIES: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 385 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 386 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 387 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 389 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 390 MIDDLE EAST: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 391 GCC COUNTRIES: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 392 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 393 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 394 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 395 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 396 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 398 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 399 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 400 TARGET DISCOVERY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 401 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 402 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 403 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 404 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 405 MIDDLE EAST: TARGET DISCOVERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 406 GCC COUNTRIES: TARGET DISCOVERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 407 LEAD IDENTIFICATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 408 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 409 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 410 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 411 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 412 MIDDLE EAST: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 413 GCC COUNTRIES: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 414 LEAD OPTIMIZATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 415 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 416 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 417 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 418 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 419 MIDDLE EAST: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 421 PRECLINICAL STUDIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 422 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 423 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 424 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 425 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 426 MIDDLE EAST: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 427 GCC COUNTRIES: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 428 PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 429 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 430 EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 431 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 432 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 433 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 434 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 435 PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 436 PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 437 NORTH AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 438 EUROPE: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 439 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 440 LATIN AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 441 MIDDLE EAST: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 442 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 443 PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 444 NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 445 EUROPE: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 446 ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 447 LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 448 MIDDLE EAST: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 449 GCC COUNTRIES: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 450 PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 451 NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 452 EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 453 ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 455 MIDDLE EAST: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 456 GCC COUNTRIES: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 457 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 458 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 459 EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 460 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 462 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 463 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 464 PROTEOMICS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 465 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 466 EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 467 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 468 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 469 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 470 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 471 PROTEOMICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 472 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 473 NORTH AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 474 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 475 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 476 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 477 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 478 NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 479 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 480 NORTH AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 481 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 482 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 483 NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 484 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 485 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 486 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 487 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 488 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 489 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 490 US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 491 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 492 US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 493 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 494 US: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 495 US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 496 US: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 497 US: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 498 US: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 499 US: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 500 US: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 501 US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 502 US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 503 US: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 504 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 505 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 506 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 507 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 508 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 509 CANADA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 510 CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 511 CANADA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 512 CANADA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 513 CANADA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 514 CANADA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 515 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 516 CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 517 CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 518 CANADA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 519 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 520 EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 521 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 522 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 523 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 524 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 525 EUROPE: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 526 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 527 EUROPE: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 528 EUROPE: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 529 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 530 EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 531 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 532 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 533 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 534 EUROPE: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 535 EUROPE: KEY MACROINDICATORS
  • TABLE 536 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 537 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 538 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 539 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 540 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 541 GERMANY: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 542 GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 543 GERMANY: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 544 GERMANY: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 545 GERMANY: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 546 GERMANY: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 547 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 548 GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 549 GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 550 GERMANY: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 551 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 552 UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 553 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 554 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 555 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 556 UK: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 557 UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 558 UK: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 559 UK: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 560 UK: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 561 UK: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 562 UK: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 563 UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 564 UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 565 UK: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 566 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 567 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 568 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 569 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 570 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 571 FRANCE: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 572 FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 573 FRANCE: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 574 FRANCE: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 575 FRANCE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 576 FRANCE: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 577 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 578 FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 579 FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 580 FRANCE: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 581 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 582 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 583 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 584 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 585 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 586 SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 587 SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 588 SWITZERLAND: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 589 SWITZERLAND: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 590 SWITZERLAND: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 591 SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 592 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 593 SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 594 SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 595 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 596 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 597 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 598 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 599 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 600 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 601 ITALY: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 602 ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 603 ITALY: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 604 ITALY: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 605 ITALY: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 606 ITALY: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 607 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 608 ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 609 ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 610 ITALY: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 611 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 612 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 613 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 614 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 615 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 616 SPAIN: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 617 SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 618 SPAIN: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 619 SPAIN: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 620 SPAIN: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 621 SPAIN: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 622 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 623 SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 624 SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 625 SPAIN: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 626 REST OF EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 627 REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 628 REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 629 REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 630 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 631 REST OF EUROPE: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 632 REST OF EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 633 REST OF EUROPE: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 634 REST OF EUROPE: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 635 REST OF EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 636 REST OF EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 637 REST OF EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 638 REST OF EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 639 REST OF EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 640 REST OF EUROPE: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 641 ASIA PACIFIC: PROTEOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 642 ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 643 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 644 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 645 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 646 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 647 ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 648 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 649 ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 650 ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 651 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 652 ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 653 ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 654 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 655 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 656 ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 657 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 658 CHINA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 659 CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 660 CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 661 CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 662 CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 663 CHINA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 664 CHINA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 665 CHINA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 666 CHINA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 667 CHINA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 668 CHINA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 669 CHINA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 670 CHINA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 671 CHINA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 672 CHINA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 673 JAPAN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 674 JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 675 JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 676 JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 677 JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 678 JAPAN: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 679 JAPAN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 680 JAPAN: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 681 JAPAN: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 682 JAPAN: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 683 JAPAN: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 684 JAPAN: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 685 JAPAN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 686 JAPAN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 687 JAPAN: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 688 INDIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 689 INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 690 INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 691 INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 692 INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 693 INDIA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 694 INDIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 695 INDIA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 696 INDIA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 697 INDIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 698 INDIA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 699 INDIA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 700 INDIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 701 INDIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 702 INDIA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 703 SOUTH KOREA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 704 SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 705 SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 706 SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 707 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 708 SOUTH KOREA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 709 SOUTH KOREA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 710 SOUTH KOREA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 711 SOUTH KOREA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 712 SOUTH KOREA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 713 SOUTH KOREA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 714 SOUTH KOREA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 715 SOUTH KOREA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 716 SOUTH KOREA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 717 SOUTH KOREA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 718 AUSTRALIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 719 AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 720 AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 721 AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 722 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 723 AUSTRALIA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 724 AUSTRALIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 725 AUSTRALIA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 726 AUSTRALIA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 727 AUSTRALIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 728 AUSTRALIA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 729 AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 730 AUSTRALIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 731 AUSTRALIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 732 AUSTRALIA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 733 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 734 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 735 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 736 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 737 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 738 REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 739 REST OF ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 740 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 741 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 742 REST OF ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 743 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 744 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 745 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 746 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 747 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 748 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 749 LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 750 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 751 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 752 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 753 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 754 LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 755 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 756 LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 757 LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 758 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 759 LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 760 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 761 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 762 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 763 LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 764 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 765 BRAZIL: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 766 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 767 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 768 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 769 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 770 BRAZIL: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 771 BRAZIL: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 772 BRAZIL: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 773 BRAZIL: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 774 BRAZIL: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 775 BRAZIL: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 776 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 777 BRAZIL: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 778 BRAZIL: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 779 BRAZIL: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 780 MEXICO: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 781 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 782 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 783 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 784 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 785 MEXICO: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 786 MEXICO: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 787 MEXICO: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 788 MEXICO: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 789 MEXICO: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 790 MEXICO: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 791 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 792 MEXICO: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 793 MEXICO: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 794 MEXICO: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 795 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 796 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 797 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 798 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 799 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 800 REST OF LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 801 REST OF LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 802 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 803 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 804 REST OF LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 805 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 806 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 807 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 808 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 809 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 810 MIDDLE EAST: PROTEOMICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 811 MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 812 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 813 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 814 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 815 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 816 MIDDLE EAST: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 817 MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 818 MIDDLE EAST: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 819 MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 820 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 821 MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 822 MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 823 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 824 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 825 MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 826 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 827 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 828 GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 829 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 830 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 831 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 832 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 833 GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 834 GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 835 GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 836 GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 837 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 838 GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 839 GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 840 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 841 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 842 GCC COUNTRIES: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 843 SAUDI ARABIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 844 SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 845 SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 846 SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 847 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 848 SAUDI ARABIA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 849 SAUDI ARABIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 850 SAUDI ARABIA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 851 SAUDI ARABIA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 852 SAUDI ARABIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 853 SAUDI ARABIA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 854 SAUDI ARABIA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 855 SAUDI ARABIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 856 SAUDI ARABIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 857 SAUDI ARABIA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 858 UAE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 859 UAE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 860 UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 861 UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 862 UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 863 UAE: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 864 UAE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 865 UAE: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 866 UAE: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 867 UAE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 868 UAE: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 869 UAE: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 870 UAE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 871 UAE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 872 UAE: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 873 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 874 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 875 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 876 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 877 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 878 REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 879 REST OF GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 880 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 881 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 882 REST OF GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 883 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 884 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 885 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 886 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 887 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 888 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 889 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 890 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 891 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 892 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 893 REST OF MIDDLE EAST: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 894 REST OF MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 895 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 896 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 897 REST OF MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 898 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 899 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 900 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 901 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 902 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 903 AFRICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 904 AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 905 AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 906 AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 907 AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 908 AFRICA: BIOCHIPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 909 AFRICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 910 AFRICA: PROTEOMICS MARKET, BY REAGENT, 2022-2029 (USD MILLION)
  • TABLE 911 AFRICA: PROTEOMICS MARKET, BY SERVICE, 2022-2029 (USD MILLION)
  • TABLE 912 AFRICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 913 AFRICA: PROTEOMICS MARKET, BY SOFTWARE, 2022-2029 (USD MILLION)
  • TABLE 914 AFRICA: PROTEOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 915 AFRICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 916 AFRICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 917 AFRICA: PROTEOMICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 918 AFRICA: KEY MACROINDICATORS
  • TABLE 919 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEOMICS MARKET
  • TABLE 920 PROTEOMICS MARKET: DEGREE OF COMPETITION
  • TABLE 921 PROTEOMICS MARKET: INSTRUMENTATION TECHNOLOGY FOOTPRINT
  • TABLE 922 PROTEOMICS MARKET: REAGENT FOOTPRINT
  • TABLE 923 PROTEOMICS MARKET: SERVICE FOOTPRINT
  • TABLE 924 PROTEOMICS MARKET: SOFTWARE FOOTPRINT
  • TABLE 925 PROTEOMICS MARKET: REGION FOOTPRINT
  • TABLE 926 PROTEOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 927 PROTEOMICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 928 PROTEOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 929 PROTEOMICS MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 930 PROTEOMICS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 931 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 932 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 933 THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 934 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 935 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 936 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 937 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 938 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 939 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 940 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 941 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 942 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 943 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 944 DANAHER CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 945 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 946 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 947 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 948 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 949 WATERS CORPORATION: COMPANY OVERVIEW
  • TABLE 950 WATERS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 951 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 952 WATERS CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 953 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 954 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 955 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 956 BRUKER: COMPANY OVERVIEW
  • TABLE 957 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 958 BRUKER: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 959 BRUKER: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 960 REVVITY: COMPANY OVERVIEW
  • TABLE 961 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 962 REVVITY: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 963 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 964 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 965 ILLUMINA, INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 966 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 967 PROMEGA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 968 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 969 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 970 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 971 QIAGEN: COMPANY OVERVIEW
  • TABLE 972 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 973 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 974 QIAGEN: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 975 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 976 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 977 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 978 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 979 PROTAGENE: COMPANY OVERVIEW
  • TABLE 980 PROTAGENE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 981 CREATIVE PROTEOMICS, US: COMPANY OVERVIEW
  • TABLE 982 HORIBA JAPAN LTD.: COMPANY OVERVIEW
  • TABLE 983 SENGENICS CORPORATION LLC: COMPANY OVERVIEW
  • TABLE 984 LABVANTAGE-BIOMAX GERMANY GMBH: COMPANY OVERVIEW
  • TABLE 985 FIOS GENOMICS: COMPANY OVERVIEW
  • TABLE 986 AZENTA US, INC.: COMPANY OVERVIEW
  • TABLE 987 MEDGENOME: COMPANY OVERVIEW
  • TABLE 988 BIOGNOSYS AG: COMPANY OVERVIEW
  • TABLE 989 MACROGEN, INC.: COMPANY OVERVIEW
  • TABLE 990 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PROTEOMICS MARKET: SEGMENTS CONSIDERED
  • FIGURE 2 PROTEOMICS MARKET: YEARS CONSIDERED
  • FIGURE 3 PROTEOMICS MARKET: RESEARCH DESIGN
  • FIGURE 4 PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 8 PROTEOMICS MARKET: MARKET VALIDATION FROM PRIMARY EXPERTS
  • FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 10 PROTEOMICS MARKET: CAGR PROJECTION
  • FIGURE 11 PROTEOMICS MARKET: DATA TRIANGULATION
  • FIGURE 12 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PROTEOMICS MARKET, BY REAGENT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PROTEOMICS MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PROTEOMICS MARKET, BY SOFTWARE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PROTEOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 PROTEOMICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 PROTEOMICS MARKET: REGIONAL GROWTH OPPORTUNITIES
  • FIGURE 19 INCREASED R&D INVESTMENTS AND HIGH DEMAND FOR PERSONALIZED MEDICINES TO DRIVE MARKET
  • FIGURE 20 US AND CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PROTEOMICS MARKET IN 2023
  • FIGURE 21 MASS SPECTROMETRY SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 23 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 PERSONALIZED MEDICINES APPROVED BY FDA, 2015-2023
  • FIGURE 25 PROTEOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 26 INDICATIVE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS, BY REGION, 2023 (USD THOUSAND)
  • FIGURE 27 PROTEOMICS PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 PROTEOMICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 NUMBER OF PATENTS GRANTED ANNUALLY, 2013-2023
  • FIGURE 31 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2013-2023
  • FIGURE 32 PROTEOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 KEY BUYING CRITERIA FOR TOP FOUR END USERS
  • FIGURE 34 PROTEOMICS MARKET: IMPACT OF AI/GEN AI
  • FIGURE 35 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET (2021-2023)
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET (2023)
  • FIGURE 39 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 PROTEOMICS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 PROTEOMICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 46 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 49 SHIMADZU CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 WATERS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 52 BRUKER: COMPANY SNAPSHOT
  • FIGURE 53 REVVITY: COMPANY SNAPSHOT
  • FIGURE 54 ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 55 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 56 QIAGEN: COMPANY SNAPSHOT
  • FIGURE 57 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT